Global Exosome Detection and Diagnosis Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Exosome Detection and Diagnosis market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Exosomes are small extracellular vesicles released by various cells into the extracellular space. They contain proteins, lipids, and nucleic acids, playing a role in intercellular communication.
The Global Info Research report includes an overview of the development of the Exosome Detection and Diagnosis industry chain, the market status of Cancers (Kits & Reagents, Instruments), Neurodegenerative Diseases (Kits & Reagents, Instruments), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Exosome Detection and Diagnosis.
Regionally, the report analyzes the Exosome Detection and Diagnosis markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Exosome Detection and Diagnosis market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Exosome Detection and Diagnosis market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Exosome Detection and Diagnosis industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Kits & Reagents, Instruments).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Exosome Detection and Diagnosis market.
Regional Analysis: The report involves examining the Exosome Detection and Diagnosis market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Exosome Detection and Diagnosis market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Exosome Detection and Diagnosis:
Company Analysis: Report covers individual Exosome Detection and Diagnosis players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Exosome Detection and Diagnosis This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cancers, Neurodegenerative Diseases).
Technology Analysis: Report covers specific technologies relevant to Exosome Detection and Diagnosis. It assesses the current state, advancements, and potential future developments in Exosome Detection and Diagnosis areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Exosome Detection and Diagnosis market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Exosome Detection and Diagnosis market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Exosome Detection and Diagnosis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Exosome Detection and Diagnosis, with revenue, gross margin and global market share of Exosome Detection and Diagnosis from 2019 to 2024.
Chapter 3, the Exosome Detection and Diagnosis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Exosome Detection and Diagnosis market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Exosome Detection and Diagnosis.
Chapter 13, to describe Exosome Detection and Diagnosis research findings and conclusion.
Exosomes are small extracellular vesicles released by various cells into the extracellular space. They contain proteins, lipids, and nucleic acids, playing a role in intercellular communication.
The Global Info Research report includes an overview of the development of the Exosome Detection and Diagnosis industry chain, the market status of Cancers (Kits & Reagents, Instruments), Neurodegenerative Diseases (Kits & Reagents, Instruments), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Exosome Detection and Diagnosis.
Regionally, the report analyzes the Exosome Detection and Diagnosis markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Exosome Detection and Diagnosis market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Exosome Detection and Diagnosis market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Exosome Detection and Diagnosis industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Kits & Reagents, Instruments).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Exosome Detection and Diagnosis market.
Regional Analysis: The report involves examining the Exosome Detection and Diagnosis market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Exosome Detection and Diagnosis market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Exosome Detection and Diagnosis:
Company Analysis: Report covers individual Exosome Detection and Diagnosis players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Exosome Detection and Diagnosis This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cancers, Neurodegenerative Diseases).
Technology Analysis: Report covers specific technologies relevant to Exosome Detection and Diagnosis. It assesses the current state, advancements, and potential future developments in Exosome Detection and Diagnosis areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Exosome Detection and Diagnosis market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Exosome Detection and Diagnosis market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Kits & Reagents
- Instruments
- Services
- Cancers
- Neurodegenerative Diseases
- Cardiovascular Diseases
- Infectious Diseases
- Other
- Thermo Fisher Scientific
- Bio-Techne
- System Biosciences
- QIAGEN
- Lonza
- NX Pharmagen
- NanoSomiX
- Miltenyi Biotech
- Norgen Biotek
- AMSBio
- Aethlon Medical
- Anjarium Biosciences
- Ciloa
- InnovaPrep
- Creative Medical Technologies
- ILIAS Biologics
- Unchained Labs
- Rion
- Cell Guidance System
- INOVIQ
- Danaher
- Exopharm
- Everzom
- RoosterBio
- Creative Biolabs
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Exosome Detection and Diagnosis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Exosome Detection and Diagnosis, with revenue, gross margin and global market share of Exosome Detection and Diagnosis from 2019 to 2024.
Chapter 3, the Exosome Detection and Diagnosis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Exosome Detection and Diagnosis market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Exosome Detection and Diagnosis.
Chapter 13, to describe Exosome Detection and Diagnosis research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Exosome Detection and Diagnosis
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Exosome Detection and Diagnosis by Type
1.3.1 Overview: Global Exosome Detection and Diagnosis Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Exosome Detection and Diagnosis Consumption Value Market Share by Type in 2023
1.3.3 Kits & Reagents
1.3.4 Instruments
1.3.5 Services
1.4 Global Exosome Detection and Diagnosis Market by Application
1.4.1 Overview: Global Exosome Detection and Diagnosis Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Cancers
1.4.3 Neurodegenerative Diseases
1.4.4 Cardiovascular Diseases
1.4.5 Infectious Diseases
1.4.6 Other
1.5 Global Exosome Detection and Diagnosis Market Size & Forecast
1.6 Global Exosome Detection and Diagnosis Market Size and Forecast by Region
1.6.1 Global Exosome Detection and Diagnosis Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Exosome Detection and Diagnosis Market Size by Region, (2019-2030)
1.6.3 North America Exosome Detection and Diagnosis Market Size and Prospect (2019-2030)
1.6.4 Europe Exosome Detection and Diagnosis Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Exosome Detection and Diagnosis Market Size and Prospect (2019-2030)
1.6.6 South America Exosome Detection and Diagnosis Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Exosome Detection and Diagnosis Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Exosome Detection and Diagnosis Product and Solutions
2.1.4 Thermo Fisher Scientific Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Bio-Techne
2.2.1 Bio-Techne Details
2.2.2 Bio-Techne Major Business
2.2.3 Bio-Techne Exosome Detection and Diagnosis Product and Solutions
2.2.4 Bio-Techne Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bio-Techne Recent Developments and Future Plans
2.3 System Biosciences
2.3.1 System Biosciences Details
2.3.2 System Biosciences Major Business
2.3.3 System Biosciences Exosome Detection and Diagnosis Product and Solutions
2.3.4 System Biosciences Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 System Biosciences Recent Developments and Future Plans
2.4 QIAGEN
2.4.1 QIAGEN Details
2.4.2 QIAGEN Major Business
2.4.3 QIAGEN Exosome Detection and Diagnosis Product and Solutions
2.4.4 QIAGEN Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 QIAGEN Recent Developments and Future Plans
2.5 Lonza
2.5.1 Lonza Details
2.5.2 Lonza Major Business
2.5.3 Lonza Exosome Detection and Diagnosis Product and Solutions
2.5.4 Lonza Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Lonza Recent Developments and Future Plans
2.6 NX Pharmagen
2.6.1 NX Pharmagen Details
2.6.2 NX Pharmagen Major Business
2.6.3 NX Pharmagen Exosome Detection and Diagnosis Product and Solutions
2.6.4 NX Pharmagen Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 NX Pharmagen Recent Developments and Future Plans
2.7 NanoSomiX
2.7.1 NanoSomiX Details
2.7.2 NanoSomiX Major Business
2.7.3 NanoSomiX Exosome Detection and Diagnosis Product and Solutions
2.7.4 NanoSomiX Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 NanoSomiX Recent Developments and Future Plans
2.8 Miltenyi Biotech
2.8.1 Miltenyi Biotech Details
2.8.2 Miltenyi Biotech Major Business
2.8.3 Miltenyi Biotech Exosome Detection and Diagnosis Product and Solutions
2.8.4 Miltenyi Biotech Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Miltenyi Biotech Recent Developments and Future Plans
2.9 Norgen Biotek
2.9.1 Norgen Biotek Details
2.9.2 Norgen Biotek Major Business
2.9.3 Norgen Biotek Exosome Detection and Diagnosis Product and Solutions
2.9.4 Norgen Biotek Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Norgen Biotek Recent Developments and Future Plans
2.10 AMSBio
2.10.1 AMSBio Details
2.10.2 AMSBio Major Business
2.10.3 AMSBio Exosome Detection and Diagnosis Product and Solutions
2.10.4 AMSBio Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 AMSBio Recent Developments and Future Plans
2.11 Aethlon Medical
2.11.1 Aethlon Medical Details
2.11.2 Aethlon Medical Major Business
2.11.3 Aethlon Medical Exosome Detection and Diagnosis Product and Solutions
2.11.4 Aethlon Medical Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Aethlon Medical Recent Developments and Future Plans
2.12 Anjarium Biosciences
2.12.1 Anjarium Biosciences Details
2.12.2 Anjarium Biosciences Major Business
2.12.3 Anjarium Biosciences Exosome Detection and Diagnosis Product and Solutions
2.12.4 Anjarium Biosciences Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Anjarium Biosciences Recent Developments and Future Plans
2.13 Ciloa
2.13.1 Ciloa Details
2.13.2 Ciloa Major Business
2.13.3 Ciloa Exosome Detection and Diagnosis Product and Solutions
2.13.4 Ciloa Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Ciloa Recent Developments and Future Plans
2.14 InnovaPrep
2.14.1 InnovaPrep Details
2.14.2 InnovaPrep Major Business
2.14.3 InnovaPrep Exosome Detection and Diagnosis Product and Solutions
2.14.4 InnovaPrep Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 InnovaPrep Recent Developments and Future Plans
2.15 Creative Medical Technologies
2.15.1 Creative Medical Technologies Details
2.15.2 Creative Medical Technologies Major Business
2.15.3 Creative Medical Technologies Exosome Detection and Diagnosis Product and Solutions
2.15.4 Creative Medical Technologies Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Creative Medical Technologies Recent Developments and Future Plans
2.16 ILIAS Biologics
2.16.1 ILIAS Biologics Details
2.16.2 ILIAS Biologics Major Business
2.16.3 ILIAS Biologics Exosome Detection and Diagnosis Product and Solutions
2.16.4 ILIAS Biologics Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 ILIAS Biologics Recent Developments and Future Plans
2.17 Unchained Labs
2.17.1 Unchained Labs Details
2.17.2 Unchained Labs Major Business
2.17.3 Unchained Labs Exosome Detection and Diagnosis Product and Solutions
2.17.4 Unchained Labs Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Unchained Labs Recent Developments and Future Plans
2.18 Rion
2.18.1 Rion Details
2.18.2 Rion Major Business
2.18.3 Rion Exosome Detection and Diagnosis Product and Solutions
2.18.4 Rion Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Rion Recent Developments and Future Plans
2.19 Cell Guidance System
2.19.1 Cell Guidance System Details
2.19.2 Cell Guidance System Major Business
2.19.3 Cell Guidance System Exosome Detection and Diagnosis Product and Solutions
2.19.4 Cell Guidance System Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Cell Guidance System Recent Developments and Future Plans
2.20 INOVIQ
2.20.1 INOVIQ Details
2.20.2 INOVIQ Major Business
2.20.3 INOVIQ Exosome Detection and Diagnosis Product and Solutions
2.20.4 INOVIQ Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 INOVIQ Recent Developments and Future Plans
2.21 Danaher
2.21.1 Danaher Details
2.21.2 Danaher Major Business
2.21.3 Danaher Exosome Detection and Diagnosis Product and Solutions
2.21.4 Danaher Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Danaher Recent Developments and Future Plans
2.22 Exopharm
2.22.1 Exopharm Details
2.22.2 Exopharm Major Business
2.22.3 Exopharm Exosome Detection and Diagnosis Product and Solutions
2.22.4 Exopharm Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Exopharm Recent Developments and Future Plans
2.23 Everzom
2.23.1 Everzom Details
2.23.2 Everzom Major Business
2.23.3 Everzom Exosome Detection and Diagnosis Product and Solutions
2.23.4 Everzom Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.23.5 Everzom Recent Developments and Future Plans
2.24 RoosterBio
2.24.1 RoosterBio Details
2.24.2 RoosterBio Major Business
2.24.3 RoosterBio Exosome Detection and Diagnosis Product and Solutions
2.24.4 RoosterBio Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.24.5 RoosterBio Recent Developments and Future Plans
2.25 Creative Biolabs
2.25.1 Creative Biolabs Details
2.25.2 Creative Biolabs Major Business
2.25.3 Creative Biolabs Exosome Detection and Diagnosis Product and Solutions
2.25.4 Creative Biolabs Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.25.5 Creative Biolabs Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Exosome Detection and Diagnosis Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Exosome Detection and Diagnosis by Company Revenue
3.2.2 Top 3 Exosome Detection and Diagnosis Players Market Share in 2023
3.2.3 Top 6 Exosome Detection and Diagnosis Players Market Share in 2023
3.3 Exosome Detection and Diagnosis Market: Overall Company Footprint Analysis
3.3.1 Exosome Detection and Diagnosis Market: Region Footprint
3.3.2 Exosome Detection and Diagnosis Market: Company Product Type Footprint
3.3.3 Exosome Detection and Diagnosis Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Exosome Detection and Diagnosis Consumption Value and Market Share by Type (2019-2024)
4.2 Global Exosome Detection and Diagnosis Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Exosome Detection and Diagnosis Consumption Value Market Share by Application (2019-2024)
5.2 Global Exosome Detection and Diagnosis Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Exosome Detection and Diagnosis Consumption Value by Type (2019-2030)
6.2 North America Exosome Detection and Diagnosis Consumption Value by Application (2019-2030)
6.3 North America Exosome Detection and Diagnosis Market Size by Country
6.3.1 North America Exosome Detection and Diagnosis Consumption Value by Country (2019-2030)
6.3.2 United States Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
6.3.3 Canada Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
6.3.4 Mexico Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Exosome Detection and Diagnosis Consumption Value by Type (2019-2030)
7.2 Europe Exosome Detection and Diagnosis Consumption Value by Application (2019-2030)
7.3 Europe Exosome Detection and Diagnosis Market Size by Country
7.3.1 Europe Exosome Detection and Diagnosis Consumption Value by Country (2019-2030)
7.3.2 Germany Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
7.3.3 France Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
7.3.5 Russia Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
7.3.6 Italy Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Exosome Detection and Diagnosis Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Exosome Detection and Diagnosis Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Exosome Detection and Diagnosis Market Size by Region
8.3.1 Asia-Pacific Exosome Detection and Diagnosis Consumption Value by Region (2019-2030)
8.3.2 China Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
8.3.3 Japan Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
8.3.4 South Korea Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
8.3.5 India Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
8.3.7 Australia Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Exosome Detection and Diagnosis Consumption Value by Type (2019-2030)
9.2 South America Exosome Detection and Diagnosis Consumption Value by Application (2019-2030)
9.3 South America Exosome Detection and Diagnosis Market Size by Country
9.3.1 South America Exosome Detection and Diagnosis Consumption Value by Country (2019-2030)
9.3.2 Brazil Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
9.3.3 Argentina Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Exosome Detection and Diagnosis Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Exosome Detection and Diagnosis Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Exosome Detection and Diagnosis Market Size by Country
10.3.1 Middle East & Africa Exosome Detection and Diagnosis Consumption Value by Country (2019-2030)
10.3.2 Turkey Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
10.3.4 UAE Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Exosome Detection and Diagnosis Market Drivers
11.2 Exosome Detection and Diagnosis Market Restraints
11.3 Exosome Detection and Diagnosis Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Exosome Detection and Diagnosis Industry Chain
12.2 Exosome Detection and Diagnosis Upstream Analysis
12.3 Exosome Detection and Diagnosis Midstream Analysis
12.4 Exosome Detection and Diagnosis Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Exosome Detection and Diagnosis
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Exosome Detection and Diagnosis by Type
1.3.1 Overview: Global Exosome Detection and Diagnosis Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Exosome Detection and Diagnosis Consumption Value Market Share by Type in 2023
1.3.3 Kits & Reagents
1.3.4 Instruments
1.3.5 Services
1.4 Global Exosome Detection and Diagnosis Market by Application
1.4.1 Overview: Global Exosome Detection and Diagnosis Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Cancers
1.4.3 Neurodegenerative Diseases
1.4.4 Cardiovascular Diseases
1.4.5 Infectious Diseases
1.4.6 Other
1.5 Global Exosome Detection and Diagnosis Market Size & Forecast
1.6 Global Exosome Detection and Diagnosis Market Size and Forecast by Region
1.6.1 Global Exosome Detection and Diagnosis Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Exosome Detection and Diagnosis Market Size by Region, (2019-2030)
1.6.3 North America Exosome Detection and Diagnosis Market Size and Prospect (2019-2030)
1.6.4 Europe Exosome Detection and Diagnosis Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Exosome Detection and Diagnosis Market Size and Prospect (2019-2030)
1.6.6 South America Exosome Detection and Diagnosis Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Exosome Detection and Diagnosis Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Exosome Detection and Diagnosis Product and Solutions
2.1.4 Thermo Fisher Scientific Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Bio-Techne
2.2.1 Bio-Techne Details
2.2.2 Bio-Techne Major Business
2.2.3 Bio-Techne Exosome Detection and Diagnosis Product and Solutions
2.2.4 Bio-Techne Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bio-Techne Recent Developments and Future Plans
2.3 System Biosciences
2.3.1 System Biosciences Details
2.3.2 System Biosciences Major Business
2.3.3 System Biosciences Exosome Detection and Diagnosis Product and Solutions
2.3.4 System Biosciences Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 System Biosciences Recent Developments and Future Plans
2.4 QIAGEN
2.4.1 QIAGEN Details
2.4.2 QIAGEN Major Business
2.4.3 QIAGEN Exosome Detection and Diagnosis Product and Solutions
2.4.4 QIAGEN Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 QIAGEN Recent Developments and Future Plans
2.5 Lonza
2.5.1 Lonza Details
2.5.2 Lonza Major Business
2.5.3 Lonza Exosome Detection and Diagnosis Product and Solutions
2.5.4 Lonza Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Lonza Recent Developments and Future Plans
2.6 NX Pharmagen
2.6.1 NX Pharmagen Details
2.6.2 NX Pharmagen Major Business
2.6.3 NX Pharmagen Exosome Detection and Diagnosis Product and Solutions
2.6.4 NX Pharmagen Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 NX Pharmagen Recent Developments and Future Plans
2.7 NanoSomiX
2.7.1 NanoSomiX Details
2.7.2 NanoSomiX Major Business
2.7.3 NanoSomiX Exosome Detection and Diagnosis Product and Solutions
2.7.4 NanoSomiX Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 NanoSomiX Recent Developments and Future Plans
2.8 Miltenyi Biotech
2.8.1 Miltenyi Biotech Details
2.8.2 Miltenyi Biotech Major Business
2.8.3 Miltenyi Biotech Exosome Detection and Diagnosis Product and Solutions
2.8.4 Miltenyi Biotech Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Miltenyi Biotech Recent Developments and Future Plans
2.9 Norgen Biotek
2.9.1 Norgen Biotek Details
2.9.2 Norgen Biotek Major Business
2.9.3 Norgen Biotek Exosome Detection and Diagnosis Product and Solutions
2.9.4 Norgen Biotek Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Norgen Biotek Recent Developments and Future Plans
2.10 AMSBio
2.10.1 AMSBio Details
2.10.2 AMSBio Major Business
2.10.3 AMSBio Exosome Detection and Diagnosis Product and Solutions
2.10.4 AMSBio Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 AMSBio Recent Developments and Future Plans
2.11 Aethlon Medical
2.11.1 Aethlon Medical Details
2.11.2 Aethlon Medical Major Business
2.11.3 Aethlon Medical Exosome Detection and Diagnosis Product and Solutions
2.11.4 Aethlon Medical Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Aethlon Medical Recent Developments and Future Plans
2.12 Anjarium Biosciences
2.12.1 Anjarium Biosciences Details
2.12.2 Anjarium Biosciences Major Business
2.12.3 Anjarium Biosciences Exosome Detection and Diagnosis Product and Solutions
2.12.4 Anjarium Biosciences Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Anjarium Biosciences Recent Developments and Future Plans
2.13 Ciloa
2.13.1 Ciloa Details
2.13.2 Ciloa Major Business
2.13.3 Ciloa Exosome Detection and Diagnosis Product and Solutions
2.13.4 Ciloa Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Ciloa Recent Developments and Future Plans
2.14 InnovaPrep
2.14.1 InnovaPrep Details
2.14.2 InnovaPrep Major Business
2.14.3 InnovaPrep Exosome Detection and Diagnosis Product and Solutions
2.14.4 InnovaPrep Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 InnovaPrep Recent Developments and Future Plans
2.15 Creative Medical Technologies
2.15.1 Creative Medical Technologies Details
2.15.2 Creative Medical Technologies Major Business
2.15.3 Creative Medical Technologies Exosome Detection and Diagnosis Product and Solutions
2.15.4 Creative Medical Technologies Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Creative Medical Technologies Recent Developments and Future Plans
2.16 ILIAS Biologics
2.16.1 ILIAS Biologics Details
2.16.2 ILIAS Biologics Major Business
2.16.3 ILIAS Biologics Exosome Detection and Diagnosis Product and Solutions
2.16.4 ILIAS Biologics Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 ILIAS Biologics Recent Developments and Future Plans
2.17 Unchained Labs
2.17.1 Unchained Labs Details
2.17.2 Unchained Labs Major Business
2.17.3 Unchained Labs Exosome Detection and Diagnosis Product and Solutions
2.17.4 Unchained Labs Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Unchained Labs Recent Developments and Future Plans
2.18 Rion
2.18.1 Rion Details
2.18.2 Rion Major Business
2.18.3 Rion Exosome Detection and Diagnosis Product and Solutions
2.18.4 Rion Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Rion Recent Developments and Future Plans
2.19 Cell Guidance System
2.19.1 Cell Guidance System Details
2.19.2 Cell Guidance System Major Business
2.19.3 Cell Guidance System Exosome Detection and Diagnosis Product and Solutions
2.19.4 Cell Guidance System Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Cell Guidance System Recent Developments and Future Plans
2.20 INOVIQ
2.20.1 INOVIQ Details
2.20.2 INOVIQ Major Business
2.20.3 INOVIQ Exosome Detection and Diagnosis Product and Solutions
2.20.4 INOVIQ Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 INOVIQ Recent Developments and Future Plans
2.21 Danaher
2.21.1 Danaher Details
2.21.2 Danaher Major Business
2.21.3 Danaher Exosome Detection and Diagnosis Product and Solutions
2.21.4 Danaher Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Danaher Recent Developments and Future Plans
2.22 Exopharm
2.22.1 Exopharm Details
2.22.2 Exopharm Major Business
2.22.3 Exopharm Exosome Detection and Diagnosis Product and Solutions
2.22.4 Exopharm Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Exopharm Recent Developments and Future Plans
2.23 Everzom
2.23.1 Everzom Details
2.23.2 Everzom Major Business
2.23.3 Everzom Exosome Detection and Diagnosis Product and Solutions
2.23.4 Everzom Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.23.5 Everzom Recent Developments and Future Plans
2.24 RoosterBio
2.24.1 RoosterBio Details
2.24.2 RoosterBio Major Business
2.24.3 RoosterBio Exosome Detection and Diagnosis Product and Solutions
2.24.4 RoosterBio Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.24.5 RoosterBio Recent Developments and Future Plans
2.25 Creative Biolabs
2.25.1 Creative Biolabs Details
2.25.2 Creative Biolabs Major Business
2.25.3 Creative Biolabs Exosome Detection and Diagnosis Product and Solutions
2.25.4 Creative Biolabs Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
2.25.5 Creative Biolabs Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Exosome Detection and Diagnosis Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Exosome Detection and Diagnosis by Company Revenue
3.2.2 Top 3 Exosome Detection and Diagnosis Players Market Share in 2023
3.2.3 Top 6 Exosome Detection and Diagnosis Players Market Share in 2023
3.3 Exosome Detection and Diagnosis Market: Overall Company Footprint Analysis
3.3.1 Exosome Detection and Diagnosis Market: Region Footprint
3.3.2 Exosome Detection and Diagnosis Market: Company Product Type Footprint
3.3.3 Exosome Detection and Diagnosis Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Exosome Detection and Diagnosis Consumption Value and Market Share by Type (2019-2024)
4.2 Global Exosome Detection and Diagnosis Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Exosome Detection and Diagnosis Consumption Value Market Share by Application (2019-2024)
5.2 Global Exosome Detection and Diagnosis Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Exosome Detection and Diagnosis Consumption Value by Type (2019-2030)
6.2 North America Exosome Detection and Diagnosis Consumption Value by Application (2019-2030)
6.3 North America Exosome Detection and Diagnosis Market Size by Country
6.3.1 North America Exosome Detection and Diagnosis Consumption Value by Country (2019-2030)
6.3.2 United States Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
6.3.3 Canada Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
6.3.4 Mexico Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Exosome Detection and Diagnosis Consumption Value by Type (2019-2030)
7.2 Europe Exosome Detection and Diagnosis Consumption Value by Application (2019-2030)
7.3 Europe Exosome Detection and Diagnosis Market Size by Country
7.3.1 Europe Exosome Detection and Diagnosis Consumption Value by Country (2019-2030)
7.3.2 Germany Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
7.3.3 France Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
7.3.5 Russia Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
7.3.6 Italy Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Exosome Detection and Diagnosis Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Exosome Detection and Diagnosis Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Exosome Detection and Diagnosis Market Size by Region
8.3.1 Asia-Pacific Exosome Detection and Diagnosis Consumption Value by Region (2019-2030)
8.3.2 China Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
8.3.3 Japan Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
8.3.4 South Korea Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
8.3.5 India Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
8.3.7 Australia Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Exosome Detection and Diagnosis Consumption Value by Type (2019-2030)
9.2 South America Exosome Detection and Diagnosis Consumption Value by Application (2019-2030)
9.3 South America Exosome Detection and Diagnosis Market Size by Country
9.3.1 South America Exosome Detection and Diagnosis Consumption Value by Country (2019-2030)
9.3.2 Brazil Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
9.3.3 Argentina Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Exosome Detection and Diagnosis Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Exosome Detection and Diagnosis Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Exosome Detection and Diagnosis Market Size by Country
10.3.1 Middle East & Africa Exosome Detection and Diagnosis Consumption Value by Country (2019-2030)
10.3.2 Turkey Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
10.3.4 UAE Exosome Detection and Diagnosis Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Exosome Detection and Diagnosis Market Drivers
11.2 Exosome Detection and Diagnosis Market Restraints
11.3 Exosome Detection and Diagnosis Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Exosome Detection and Diagnosis Industry Chain
12.2 Exosome Detection and Diagnosis Upstream Analysis
12.3 Exosome Detection and Diagnosis Midstream Analysis
12.4 Exosome Detection and Diagnosis Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Exosome Detection and Diagnosis Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Exosome Detection and Diagnosis Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Exosome Detection and Diagnosis Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Exosome Detection and Diagnosis Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 6. Thermo Fisher Scientific Major Business
Table 7. Thermo Fisher Scientific Exosome Detection and Diagnosis Product and Solutions
Table 8. Thermo Fisher Scientific Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Thermo Fisher Scientific Recent Developments and Future Plans
Table 10. Bio-Techne Company Information, Head Office, and Major Competitors
Table 11. Bio-Techne Major Business
Table 12. Bio-Techne Exosome Detection and Diagnosis Product and Solutions
Table 13. Bio-Techne Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Bio-Techne Recent Developments and Future Plans
Table 15. System Biosciences Company Information, Head Office, and Major Competitors
Table 16. System Biosciences Major Business
Table 17. System Biosciences Exosome Detection and Diagnosis Product and Solutions
Table 18. System Biosciences Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. System Biosciences Recent Developments and Future Plans
Table 20. QIAGEN Company Information, Head Office, and Major Competitors
Table 21. QIAGEN Major Business
Table 22. QIAGEN Exosome Detection and Diagnosis Product and Solutions
Table 23. QIAGEN Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. QIAGEN Recent Developments and Future Plans
Table 25. Lonza Company Information, Head Office, and Major Competitors
Table 26. Lonza Major Business
Table 27. Lonza Exosome Detection and Diagnosis Product and Solutions
Table 28. Lonza Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Lonza Recent Developments and Future Plans
Table 30. NX Pharmagen Company Information, Head Office, and Major Competitors
Table 31. NX Pharmagen Major Business
Table 32. NX Pharmagen Exosome Detection and Diagnosis Product and Solutions
Table 33. NX Pharmagen Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. NX Pharmagen Recent Developments and Future Plans
Table 35. NanoSomiX Company Information, Head Office, and Major Competitors
Table 36. NanoSomiX Major Business
Table 37. NanoSomiX Exosome Detection and Diagnosis Product and Solutions
Table 38. NanoSomiX Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. NanoSomiX Recent Developments and Future Plans
Table 40. Miltenyi Biotech Company Information, Head Office, and Major Competitors
Table 41. Miltenyi Biotech Major Business
Table 42. Miltenyi Biotech Exosome Detection and Diagnosis Product and Solutions
Table 43. Miltenyi Biotech Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Miltenyi Biotech Recent Developments and Future Plans
Table 45. Norgen Biotek Company Information, Head Office, and Major Competitors
Table 46. Norgen Biotek Major Business
Table 47. Norgen Biotek Exosome Detection and Diagnosis Product and Solutions
Table 48. Norgen Biotek Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Norgen Biotek Recent Developments and Future Plans
Table 50. AMSBio Company Information, Head Office, and Major Competitors
Table 51. AMSBio Major Business
Table 52. AMSBio Exosome Detection and Diagnosis Product and Solutions
Table 53. AMSBio Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. AMSBio Recent Developments and Future Plans
Table 55. Aethlon Medical Company Information, Head Office, and Major Competitors
Table 56. Aethlon Medical Major Business
Table 57. Aethlon Medical Exosome Detection and Diagnosis Product and Solutions
Table 58. Aethlon Medical Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Aethlon Medical Recent Developments and Future Plans
Table 60. Anjarium Biosciences Company Information, Head Office, and Major Competitors
Table 61. Anjarium Biosciences Major Business
Table 62. Anjarium Biosciences Exosome Detection and Diagnosis Product and Solutions
Table 63. Anjarium Biosciences Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Anjarium Biosciences Recent Developments and Future Plans
Table 65. Ciloa Company Information, Head Office, and Major Competitors
Table 66. Ciloa Major Business
Table 67. Ciloa Exosome Detection and Diagnosis Product and Solutions
Table 68. Ciloa Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Ciloa Recent Developments and Future Plans
Table 70. InnovaPrep Company Information, Head Office, and Major Competitors
Table 71. InnovaPrep Major Business
Table 72. InnovaPrep Exosome Detection and Diagnosis Product and Solutions
Table 73. InnovaPrep Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. InnovaPrep Recent Developments and Future Plans
Table 75. Creative Medical Technologies Company Information, Head Office, and Major Competitors
Table 76. Creative Medical Technologies Major Business
Table 77. Creative Medical Technologies Exosome Detection and Diagnosis Product and Solutions
Table 78. Creative Medical Technologies Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Creative Medical Technologies Recent Developments and Future Plans
Table 80. ILIAS Biologics Company Information, Head Office, and Major Competitors
Table 81. ILIAS Biologics Major Business
Table 82. ILIAS Biologics Exosome Detection and Diagnosis Product and Solutions
Table 83. ILIAS Biologics Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. ILIAS Biologics Recent Developments and Future Plans
Table 85. Unchained Labs Company Information, Head Office, and Major Competitors
Table 86. Unchained Labs Major Business
Table 87. Unchained Labs Exosome Detection and Diagnosis Product and Solutions
Table 88. Unchained Labs Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Unchained Labs Recent Developments and Future Plans
Table 90. Rion Company Information, Head Office, and Major Competitors
Table 91. Rion Major Business
Table 92. Rion Exosome Detection and Diagnosis Product and Solutions
Table 93. Rion Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Rion Recent Developments and Future Plans
Table 95. Cell Guidance System Company Information, Head Office, and Major Competitors
Table 96. Cell Guidance System Major Business
Table 97. Cell Guidance System Exosome Detection and Diagnosis Product and Solutions
Table 98. Cell Guidance System Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Cell Guidance System Recent Developments and Future Plans
Table 100. INOVIQ Company Information, Head Office, and Major Competitors
Table 101. INOVIQ Major Business
Table 102. INOVIQ Exosome Detection and Diagnosis Product and Solutions
Table 103. INOVIQ Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. INOVIQ Recent Developments and Future Plans
Table 105. Danaher Company Information, Head Office, and Major Competitors
Table 106. Danaher Major Business
Table 107. Danaher Exosome Detection and Diagnosis Product and Solutions
Table 108. Danaher Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 109. Danaher Recent Developments and Future Plans
Table 110. Exopharm Company Information, Head Office, and Major Competitors
Table 111. Exopharm Major Business
Table 112. Exopharm Exosome Detection and Diagnosis Product and Solutions
Table 113. Exopharm Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 114. Exopharm Recent Developments and Future Plans
Table 115. Everzom Company Information, Head Office, and Major Competitors
Table 116. Everzom Major Business
Table 117. Everzom Exosome Detection and Diagnosis Product and Solutions
Table 118. Everzom Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Everzom Recent Developments and Future Plans
Table 120. RoosterBio Company Information, Head Office, and Major Competitors
Table 121. RoosterBio Major Business
Table 122. RoosterBio Exosome Detection and Diagnosis Product and Solutions
Table 123. RoosterBio Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 124. RoosterBio Recent Developments and Future Plans
Table 125. Creative Biolabs Company Information, Head Office, and Major Competitors
Table 126. Creative Biolabs Major Business
Table 127. Creative Biolabs Exosome Detection and Diagnosis Product and Solutions
Table 128. Creative Biolabs Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 129. Creative Biolabs Recent Developments and Future Plans
Table 130. Global Exosome Detection and Diagnosis Revenue (USD Million) by Players (2019-2024)
Table 131. Global Exosome Detection and Diagnosis Revenue Share by Players (2019-2024)
Table 132. Breakdown of Exosome Detection and Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3)
Table 133. Market Position of Players in Exosome Detection and Diagnosis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 134. Head Office of Key Exosome Detection and Diagnosis Players
Table 135. Exosome Detection and Diagnosis Market: Company Product Type Footprint
Table 136. Exosome Detection and Diagnosis Market: Company Product Application Footprint
Table 137. Exosome Detection and Diagnosis New Market Entrants and Barriers to Market Entry
Table 138. Exosome Detection and Diagnosis Mergers, Acquisition, Agreements, and Collaborations
Table 139. Global Exosome Detection and Diagnosis Consumption Value (USD Million) by Type (2019-2024)
Table 140. Global Exosome Detection and Diagnosis Consumption Value Share by Type (2019-2024)
Table 141. Global Exosome Detection and Diagnosis Consumption Value Forecast by Type (2025-2030)
Table 142. Global Exosome Detection and Diagnosis Consumption Value by Application (2019-2024)
Table 143. Global Exosome Detection and Diagnosis Consumption Value Forecast by Application (2025-2030)
Table 144. North America Exosome Detection and Diagnosis Consumption Value by Type (2019-2024) & (USD Million)
Table 145. North America Exosome Detection and Diagnosis Consumption Value by Type (2025-2030) & (USD Million)
Table 146. North America Exosome Detection and Diagnosis Consumption Value by Application (2019-2024) & (USD Million)
Table 147. North America Exosome Detection and Diagnosis Consumption Value by Application (2025-2030) & (USD Million)
Table 148. North America Exosome Detection and Diagnosis Consumption Value by Country (2019-2024) & (USD Million)
Table 149. North America Exosome Detection and Diagnosis Consumption Value by Country (2025-2030) & (USD Million)
Table 150. Europe Exosome Detection and Diagnosis Consumption Value by Type (2019-2024) & (USD Million)
Table 151. Europe Exosome Detection and Diagnosis Consumption Value by Type (2025-2030) & (USD Million)
Table 152. Europe Exosome Detection and Diagnosis Consumption Value by Application (2019-2024) & (USD Million)
Table 153. Europe Exosome Detection and Diagnosis Consumption Value by Application (2025-2030) & (USD Million)
Table 154. Europe Exosome Detection and Diagnosis Consumption Value by Country (2019-2024) & (USD Million)
Table 155. Europe Exosome Detection and Diagnosis Consumption Value by Country (2025-2030) & (USD Million)
Table 156. Asia-Pacific Exosome Detection and Diagnosis Consumption Value by Type (2019-2024) & (USD Million)
Table 157. Asia-Pacific Exosome Detection and Diagnosis Consumption Value by Type (2025-2030) & (USD Million)
Table 158. Asia-Pacific Exosome Detection and Diagnosis Consumption Value by Application (2019-2024) & (USD Million)
Table 159. Asia-Pacific Exosome Detection and Diagnosis Consumption Value by Application (2025-2030) & (USD Million)
Table 160. Asia-Pacific Exosome Detection and Diagnosis Consumption Value by Region (2019-2024) & (USD Million)
Table 161. Asia-Pacific Exosome Detection and Diagnosis Consumption Value by Region (2025-2030) & (USD Million)
Table 162. South America Exosome Detection and Diagnosis Consumption Value by Type (2019-2024) & (USD Million)
Table 163. South America Exosome Detection and Diagnosis Consumption Value by Type (2025-2030) & (USD Million)
Table 164. South America Exosome Detection and Diagnosis Consumption Value by Application (2019-2024) & (USD Million)
Table 165. South America Exosome Detection and Diagnosis Consumption Value by Application (2025-2030) & (USD Million)
Table 166. South America Exosome Detection and Diagnosis Consumption Value by Country (2019-2024) & (USD Million)
Table 167. South America Exosome Detection and Diagnosis Consumption Value by Country (2025-2030) & (USD Million)
Table 168. Middle East & Africa Exosome Detection and Diagnosis Consumption Value by Type (2019-2024) & (USD Million)
Table 169. Middle East & Africa Exosome Detection and Diagnosis Consumption Value by Type (2025-2030) & (USD Million)
Table 170. Middle East & Africa Exosome Detection and Diagnosis Consumption Value by Application (2019-2024) & (USD Million)
Table 171. Middle East & Africa Exosome Detection and Diagnosis Consumption Value by Application (2025-2030) & (USD Million)
Table 172. Middle East & Africa Exosome Detection and Diagnosis Consumption Value by Country (2019-2024) & (USD Million)
Table 173. Middle East & Africa Exosome Detection and Diagnosis Consumption Value by Country (2025-2030) & (USD Million)
Table 174. Exosome Detection and Diagnosis Raw Material
Table 175. Key Suppliers of Exosome Detection and Diagnosis Raw Materials
LIST OF FIGURE
s
Figure 1. Exosome Detection and Diagnosis Picture
Figure 2. Global Exosome Detection and Diagnosis Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Exosome Detection and Diagnosis Consumption Value Market Share by Type in 2023
Figure 4. Kits & Reagents
Figure 5. Instruments
Figure 6. Services
Figure 7. Global Exosome Detection and Diagnosis Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Exosome Detection and Diagnosis Consumption Value Market Share by Application in 2023
Figure 9. Cancers Picture
Figure 10. Neurodegenerative Diseases Picture
Figure 11. Cardiovascular Diseases Picture
Figure 12. Infectious Diseases Picture
Figure 13. Other Picture
Figure 14. Global Exosome Detection and Diagnosis Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Exosome Detection and Diagnosis Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market Exosome Detection and Diagnosis Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global Exosome Detection and Diagnosis Consumption Value Market Share by Region (2019-2030)
Figure 18. Global Exosome Detection and Diagnosis Consumption Value Market Share by Region in 2023
Figure 19. North America Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 22. South America Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 24. Global Exosome Detection and Diagnosis Revenue Share by Players in 2023
Figure 25. Exosome Detection and Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players Exosome Detection and Diagnosis Market Share in 2023
Figure 27. Global Top 6 Players Exosome Detection and Diagnosis Market Share in 2023
Figure 28. Global Exosome Detection and Diagnosis Consumption Value Share by Type (2019-2024)
Figure 29. Global Exosome Detection and Diagnosis Market Share Forecast by Type (2025-2030)
Figure 30. Global Exosome Detection and Diagnosis Consumption Value Share by Application (2019-2024)
Figure 31. Global Exosome Detection and Diagnosis Market Share Forecast by Application (2025-2030)
Figure 32. North America Exosome Detection and Diagnosis Consumption Value Market Share by Type (2019-2030)
Figure 33. North America Exosome Detection and Diagnosis Consumption Value Market Share by Application (2019-2030)
Figure 34. North America Exosome Detection and Diagnosis Consumption Value Market Share by Country (2019-2030)
Figure 35. United States Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe Exosome Detection and Diagnosis Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe Exosome Detection and Diagnosis Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe Exosome Detection and Diagnosis Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 42. France Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Exosome Detection and Diagnosis Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific Exosome Detection and Diagnosis Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific Exosome Detection and Diagnosis Consumption Value Market Share by Region (2019-2030)
Figure 49. China Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 52. India Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 55. South America Exosome Detection and Diagnosis Consumption Value Market Share by Type (2019-2030)
Figure 56. South America Exosome Detection and Diagnosis Consumption Value Market Share by Application (2019-2030)
Figure 57. South America Exosome Detection and Diagnosis Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa Exosome Detection and Diagnosis Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa Exosome Detection and Diagnosis Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa Exosome Detection and Diagnosis Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 66. Exosome Detection and Diagnosis Market Drivers
Figure 67. Exosome Detection and Diagnosis Market Restraints
Figure 68. Exosome Detection and Diagnosis Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Exosome Detection and Diagnosis in 2023
Figure 71. Manufacturing Process Analysis of Exosome Detection and Diagnosis
Figure 72. Exosome Detection and Diagnosis Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Table 1. Global Exosome Detection and Diagnosis Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Exosome Detection and Diagnosis Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Exosome Detection and Diagnosis Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Exosome Detection and Diagnosis Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 6. Thermo Fisher Scientific Major Business
Table 7. Thermo Fisher Scientific Exosome Detection and Diagnosis Product and Solutions
Table 8. Thermo Fisher Scientific Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Thermo Fisher Scientific Recent Developments and Future Plans
Table 10. Bio-Techne Company Information, Head Office, and Major Competitors
Table 11. Bio-Techne Major Business
Table 12. Bio-Techne Exosome Detection and Diagnosis Product and Solutions
Table 13. Bio-Techne Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Bio-Techne Recent Developments and Future Plans
Table 15. System Biosciences Company Information, Head Office, and Major Competitors
Table 16. System Biosciences Major Business
Table 17. System Biosciences Exosome Detection and Diagnosis Product and Solutions
Table 18. System Biosciences Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. System Biosciences Recent Developments and Future Plans
Table 20. QIAGEN Company Information, Head Office, and Major Competitors
Table 21. QIAGEN Major Business
Table 22. QIAGEN Exosome Detection and Diagnosis Product and Solutions
Table 23. QIAGEN Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. QIAGEN Recent Developments and Future Plans
Table 25. Lonza Company Information, Head Office, and Major Competitors
Table 26. Lonza Major Business
Table 27. Lonza Exosome Detection and Diagnosis Product and Solutions
Table 28. Lonza Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Lonza Recent Developments and Future Plans
Table 30. NX Pharmagen Company Information, Head Office, and Major Competitors
Table 31. NX Pharmagen Major Business
Table 32. NX Pharmagen Exosome Detection and Diagnosis Product and Solutions
Table 33. NX Pharmagen Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. NX Pharmagen Recent Developments and Future Plans
Table 35. NanoSomiX Company Information, Head Office, and Major Competitors
Table 36. NanoSomiX Major Business
Table 37. NanoSomiX Exosome Detection and Diagnosis Product and Solutions
Table 38. NanoSomiX Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. NanoSomiX Recent Developments and Future Plans
Table 40. Miltenyi Biotech Company Information, Head Office, and Major Competitors
Table 41. Miltenyi Biotech Major Business
Table 42. Miltenyi Biotech Exosome Detection and Diagnosis Product and Solutions
Table 43. Miltenyi Biotech Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Miltenyi Biotech Recent Developments and Future Plans
Table 45. Norgen Biotek Company Information, Head Office, and Major Competitors
Table 46. Norgen Biotek Major Business
Table 47. Norgen Biotek Exosome Detection and Diagnosis Product and Solutions
Table 48. Norgen Biotek Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Norgen Biotek Recent Developments and Future Plans
Table 50. AMSBio Company Information, Head Office, and Major Competitors
Table 51. AMSBio Major Business
Table 52. AMSBio Exosome Detection and Diagnosis Product and Solutions
Table 53. AMSBio Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. AMSBio Recent Developments and Future Plans
Table 55. Aethlon Medical Company Information, Head Office, and Major Competitors
Table 56. Aethlon Medical Major Business
Table 57. Aethlon Medical Exosome Detection and Diagnosis Product and Solutions
Table 58. Aethlon Medical Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Aethlon Medical Recent Developments and Future Plans
Table 60. Anjarium Biosciences Company Information, Head Office, and Major Competitors
Table 61. Anjarium Biosciences Major Business
Table 62. Anjarium Biosciences Exosome Detection and Diagnosis Product and Solutions
Table 63. Anjarium Biosciences Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Anjarium Biosciences Recent Developments and Future Plans
Table 65. Ciloa Company Information, Head Office, and Major Competitors
Table 66. Ciloa Major Business
Table 67. Ciloa Exosome Detection and Diagnosis Product and Solutions
Table 68. Ciloa Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Ciloa Recent Developments and Future Plans
Table 70. InnovaPrep Company Information, Head Office, and Major Competitors
Table 71. InnovaPrep Major Business
Table 72. InnovaPrep Exosome Detection and Diagnosis Product and Solutions
Table 73. InnovaPrep Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. InnovaPrep Recent Developments and Future Plans
Table 75. Creative Medical Technologies Company Information, Head Office, and Major Competitors
Table 76. Creative Medical Technologies Major Business
Table 77. Creative Medical Technologies Exosome Detection and Diagnosis Product and Solutions
Table 78. Creative Medical Technologies Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Creative Medical Technologies Recent Developments and Future Plans
Table 80. ILIAS Biologics Company Information, Head Office, and Major Competitors
Table 81. ILIAS Biologics Major Business
Table 82. ILIAS Biologics Exosome Detection and Diagnosis Product and Solutions
Table 83. ILIAS Biologics Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. ILIAS Biologics Recent Developments and Future Plans
Table 85. Unchained Labs Company Information, Head Office, and Major Competitors
Table 86. Unchained Labs Major Business
Table 87. Unchained Labs Exosome Detection and Diagnosis Product and Solutions
Table 88. Unchained Labs Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Unchained Labs Recent Developments and Future Plans
Table 90. Rion Company Information, Head Office, and Major Competitors
Table 91. Rion Major Business
Table 92. Rion Exosome Detection and Diagnosis Product and Solutions
Table 93. Rion Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Rion Recent Developments and Future Plans
Table 95. Cell Guidance System Company Information, Head Office, and Major Competitors
Table 96. Cell Guidance System Major Business
Table 97. Cell Guidance System Exosome Detection and Diagnosis Product and Solutions
Table 98. Cell Guidance System Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Cell Guidance System Recent Developments and Future Plans
Table 100. INOVIQ Company Information, Head Office, and Major Competitors
Table 101. INOVIQ Major Business
Table 102. INOVIQ Exosome Detection and Diagnosis Product and Solutions
Table 103. INOVIQ Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. INOVIQ Recent Developments and Future Plans
Table 105. Danaher Company Information, Head Office, and Major Competitors
Table 106. Danaher Major Business
Table 107. Danaher Exosome Detection and Diagnosis Product and Solutions
Table 108. Danaher Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 109. Danaher Recent Developments and Future Plans
Table 110. Exopharm Company Information, Head Office, and Major Competitors
Table 111. Exopharm Major Business
Table 112. Exopharm Exosome Detection and Diagnosis Product and Solutions
Table 113. Exopharm Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 114. Exopharm Recent Developments and Future Plans
Table 115. Everzom Company Information, Head Office, and Major Competitors
Table 116. Everzom Major Business
Table 117. Everzom Exosome Detection and Diagnosis Product and Solutions
Table 118. Everzom Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Everzom Recent Developments and Future Plans
Table 120. RoosterBio Company Information, Head Office, and Major Competitors
Table 121. RoosterBio Major Business
Table 122. RoosterBio Exosome Detection and Diagnosis Product and Solutions
Table 123. RoosterBio Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 124. RoosterBio Recent Developments and Future Plans
Table 125. Creative Biolabs Company Information, Head Office, and Major Competitors
Table 126. Creative Biolabs Major Business
Table 127. Creative Biolabs Exosome Detection and Diagnosis Product and Solutions
Table 128. Creative Biolabs Exosome Detection and Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 129. Creative Biolabs Recent Developments and Future Plans
Table 130. Global Exosome Detection and Diagnosis Revenue (USD Million) by Players (2019-2024)
Table 131. Global Exosome Detection and Diagnosis Revenue Share by Players (2019-2024)
Table 132. Breakdown of Exosome Detection and Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3)
Table 133. Market Position of Players in Exosome Detection and Diagnosis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 134. Head Office of Key Exosome Detection and Diagnosis Players
Table 135. Exosome Detection and Diagnosis Market: Company Product Type Footprint
Table 136. Exosome Detection and Diagnosis Market: Company Product Application Footprint
Table 137. Exosome Detection and Diagnosis New Market Entrants and Barriers to Market Entry
Table 138. Exosome Detection and Diagnosis Mergers, Acquisition, Agreements, and Collaborations
Table 139. Global Exosome Detection and Diagnosis Consumption Value (USD Million) by Type (2019-2024)
Table 140. Global Exosome Detection and Diagnosis Consumption Value Share by Type (2019-2024)
Table 141. Global Exosome Detection and Diagnosis Consumption Value Forecast by Type (2025-2030)
Table 142. Global Exosome Detection and Diagnosis Consumption Value by Application (2019-2024)
Table 143. Global Exosome Detection and Diagnosis Consumption Value Forecast by Application (2025-2030)
Table 144. North America Exosome Detection and Diagnosis Consumption Value by Type (2019-2024) & (USD Million)
Table 145. North America Exosome Detection and Diagnosis Consumption Value by Type (2025-2030) & (USD Million)
Table 146. North America Exosome Detection and Diagnosis Consumption Value by Application (2019-2024) & (USD Million)
Table 147. North America Exosome Detection and Diagnosis Consumption Value by Application (2025-2030) & (USD Million)
Table 148. North America Exosome Detection and Diagnosis Consumption Value by Country (2019-2024) & (USD Million)
Table 149. North America Exosome Detection and Diagnosis Consumption Value by Country (2025-2030) & (USD Million)
Table 150. Europe Exosome Detection and Diagnosis Consumption Value by Type (2019-2024) & (USD Million)
Table 151. Europe Exosome Detection and Diagnosis Consumption Value by Type (2025-2030) & (USD Million)
Table 152. Europe Exosome Detection and Diagnosis Consumption Value by Application (2019-2024) & (USD Million)
Table 153. Europe Exosome Detection and Diagnosis Consumption Value by Application (2025-2030) & (USD Million)
Table 154. Europe Exosome Detection and Diagnosis Consumption Value by Country (2019-2024) & (USD Million)
Table 155. Europe Exosome Detection and Diagnosis Consumption Value by Country (2025-2030) & (USD Million)
Table 156. Asia-Pacific Exosome Detection and Diagnosis Consumption Value by Type (2019-2024) & (USD Million)
Table 157. Asia-Pacific Exosome Detection and Diagnosis Consumption Value by Type (2025-2030) & (USD Million)
Table 158. Asia-Pacific Exosome Detection and Diagnosis Consumption Value by Application (2019-2024) & (USD Million)
Table 159. Asia-Pacific Exosome Detection and Diagnosis Consumption Value by Application (2025-2030) & (USD Million)
Table 160. Asia-Pacific Exosome Detection and Diagnosis Consumption Value by Region (2019-2024) & (USD Million)
Table 161. Asia-Pacific Exosome Detection and Diagnosis Consumption Value by Region (2025-2030) & (USD Million)
Table 162. South America Exosome Detection and Diagnosis Consumption Value by Type (2019-2024) & (USD Million)
Table 163. South America Exosome Detection and Diagnosis Consumption Value by Type (2025-2030) & (USD Million)
Table 164. South America Exosome Detection and Diagnosis Consumption Value by Application (2019-2024) & (USD Million)
Table 165. South America Exosome Detection and Diagnosis Consumption Value by Application (2025-2030) & (USD Million)
Table 166. South America Exosome Detection and Diagnosis Consumption Value by Country (2019-2024) & (USD Million)
Table 167. South America Exosome Detection and Diagnosis Consumption Value by Country (2025-2030) & (USD Million)
Table 168. Middle East & Africa Exosome Detection and Diagnosis Consumption Value by Type (2019-2024) & (USD Million)
Table 169. Middle East & Africa Exosome Detection and Diagnosis Consumption Value by Type (2025-2030) & (USD Million)
Table 170. Middle East & Africa Exosome Detection and Diagnosis Consumption Value by Application (2019-2024) & (USD Million)
Table 171. Middle East & Africa Exosome Detection and Diagnosis Consumption Value by Application (2025-2030) & (USD Million)
Table 172. Middle East & Africa Exosome Detection and Diagnosis Consumption Value by Country (2019-2024) & (USD Million)
Table 173. Middle East & Africa Exosome Detection and Diagnosis Consumption Value by Country (2025-2030) & (USD Million)
Table 174. Exosome Detection and Diagnosis Raw Material
Table 175. Key Suppliers of Exosome Detection and Diagnosis Raw Materials
LIST OF FIGURE
s
Figure 1. Exosome Detection and Diagnosis Picture
Figure 2. Global Exosome Detection and Diagnosis Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Exosome Detection and Diagnosis Consumption Value Market Share by Type in 2023
Figure 4. Kits & Reagents
Figure 5. Instruments
Figure 6. Services
Figure 7. Global Exosome Detection and Diagnosis Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Exosome Detection and Diagnosis Consumption Value Market Share by Application in 2023
Figure 9. Cancers Picture
Figure 10. Neurodegenerative Diseases Picture
Figure 11. Cardiovascular Diseases Picture
Figure 12. Infectious Diseases Picture
Figure 13. Other Picture
Figure 14. Global Exosome Detection and Diagnosis Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Exosome Detection and Diagnosis Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market Exosome Detection and Diagnosis Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global Exosome Detection and Diagnosis Consumption Value Market Share by Region (2019-2030)
Figure 18. Global Exosome Detection and Diagnosis Consumption Value Market Share by Region in 2023
Figure 19. North America Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 22. South America Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 24. Global Exosome Detection and Diagnosis Revenue Share by Players in 2023
Figure 25. Exosome Detection and Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players Exosome Detection and Diagnosis Market Share in 2023
Figure 27. Global Top 6 Players Exosome Detection and Diagnosis Market Share in 2023
Figure 28. Global Exosome Detection and Diagnosis Consumption Value Share by Type (2019-2024)
Figure 29. Global Exosome Detection and Diagnosis Market Share Forecast by Type (2025-2030)
Figure 30. Global Exosome Detection and Diagnosis Consumption Value Share by Application (2019-2024)
Figure 31. Global Exosome Detection and Diagnosis Market Share Forecast by Application (2025-2030)
Figure 32. North America Exosome Detection and Diagnosis Consumption Value Market Share by Type (2019-2030)
Figure 33. North America Exosome Detection and Diagnosis Consumption Value Market Share by Application (2019-2030)
Figure 34. North America Exosome Detection and Diagnosis Consumption Value Market Share by Country (2019-2030)
Figure 35. United States Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe Exosome Detection and Diagnosis Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe Exosome Detection and Diagnosis Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe Exosome Detection and Diagnosis Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 42. France Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Exosome Detection and Diagnosis Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific Exosome Detection and Diagnosis Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific Exosome Detection and Diagnosis Consumption Value Market Share by Region (2019-2030)
Figure 49. China Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 52. India Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 55. South America Exosome Detection and Diagnosis Consumption Value Market Share by Type (2019-2030)
Figure 56. South America Exosome Detection and Diagnosis Consumption Value Market Share by Application (2019-2030)
Figure 57. South America Exosome Detection and Diagnosis Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa Exosome Detection and Diagnosis Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa Exosome Detection and Diagnosis Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa Exosome Detection and Diagnosis Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 66. Exosome Detection and Diagnosis Market Drivers
Figure 67. Exosome Detection and Diagnosis Market Restraints
Figure 68. Exosome Detection and Diagnosis Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Exosome Detection and Diagnosis in 2023
Figure 71. Manufacturing Process Analysis of Exosome Detection and Diagnosis
Figure 72. Exosome Detection and Diagnosis Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
